Literature DB >> 10617621

Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage.

S Kharbanda1, S Saxena, K Yoshida, P Pandey, M Kaneki, Q Wang, K Cheng, Y N Chen, A Campbell, T Sudha, Z M Yuan, J Narula, R Weichselbaum, C Nalin, D Kufe.   

Abstract

Activation of the stress-activated protein kinase (SAPK/JNK) by genotoxic agents is necessary for induction of apoptosis. We report here that ionizing radiation ionizing radiation exposure induces translocation of SAPK to mitochondria and association of SAPK with the anti-apoptotic Bcl-x(L) protein. SAPK phosphorylates Bcl-x(L) on threonine 47 (Thr-47) and threonine 115 (Thr-115) in vitro and in vivo. In contrast to wild-type Bcl-x(L), a mutant Bcl-x(L) with the two threonines substituted by alanines (Ala-47, Ala-115) is a more potent inhibitor of ionizing radiation-induced apoptosis. These findings indicate that translocation of SAPK to mitochondria is functionally important for interactions with Bcl-x(L) in the apoptotic response to genotoxic stress.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10617621     DOI: 10.1074/jbc.275.1.322

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  124 in total

1.  Targeting of the c-Abl tyrosine kinase to mitochondria in endoplasmic reticulum stress-induced apoptosis.

Authors:  Y Ito; P Pandey; N Mishra; S Kumar; N Narula; S Kharbanda; S Saxena; D Kufe
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

Review 2.  Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress.

Authors:  Mohammed Akbar; Musthafa Mohamed Essa; Ghazi Daradkeh; Mohamed A Abdelmegeed; Youngshim Choi; Lubna Mahmood; Byoung-Joon Song
Journal:  Brain Res       Date:  2016-02-13       Impact factor: 3.252

3.  p38 mitogen-activated protein kinase mediates the Fas-induced mitochondrial death pathway in CD8+ T cells.

Authors:  Nicholas Farley; Gustavo Pedraza-Alva; Diego Serrano-Gomez; Viswas Nagaleekar; Alexander Aronshtam; Troy Krahl; Tina Thornton; Mercedes Rincón
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

Review 4.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

5.  Enhancing CHK1 inhibitor lethality in glioblastoma.

Authors:  Yong Tang; Yun Dai; Steven Grant; Paul Dent
Journal:  Cancer Biol Ther       Date:  2012-04-01       Impact factor: 4.742

Review 6.  Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease.

Authors:  Robert E Burke
Journal:  Pharmacol Ther       Date:  2007-02-27       Impact factor: 12.310

7.  A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria.

Authors:  Carolyn Wiltshire; Masato Matsushita; Satoshi Tsukada; David A F Gillespie; Gerhard H W May
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

8.  Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity.

Authors:  Harmeet Malhi; Fernando J Barreyro; Hajime Isomoto; Steven F Bronk; Gregory J Gores
Journal:  Gut       Date:  2007-04-30       Impact factor: 23.059

9.  Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition.

Authors:  Andrea Rasola; Marco Sciacovelli; Federica Chiara; Boris Pantic; William S Brusilow; Paolo Bernardi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

10.  JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins.

Authors:  Fuminori Tsuruta; Jun Sunayama; Yasunori Mori; Seisuke Hattori; Shigeomi Shimizu; Yoshihide Tsujimoto; Katsuji Yoshioka; Norihisa Masuyama; Yukiko Gotoh
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.